
Caplin Point Laboratories Ltd Shows Technical Momentum Shift Amid Mixed Indicators
2026-05-20 08:02:52Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. This change is underscored by a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a nuanced outlook for investors as the stock trades near ₹2,038.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30-Jul-2026 | Source : BSEPost-results conference call invite for the quarter ended June 30 2026 is enclosed herewith.
Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend If Any.
29-Jul-2026 | Source : BSECaplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve 1. Unaudited financial results of the Company for the Quarter ended June 30 2026 (both Standalone & Consolidated) 2. recommendation of Final Dividend if any for the FY 2025-26 and fixation of record date for this purpose.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
11-Jul-2026 | Source : BSEIntimation pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended June 30 2026
Corporate Actions
12 Aug 2026
Caplin Point Laboratories Ltd has declared 200% dividend, ex-date: 29 May 26
Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16
No Bonus history available
No Rights history available